Literature DB >> 32706527

Promoting emotional wellness in children with CF, part II: Mental health assessment and intervention.

Anna M Georgiopoulos1, Lillian M Christon2, Stephanie S Filigno3,4, Amy Mueller5, Mary G Prieur6, Thomas F Boat3,4, Beth A Smith7.   

Abstract

This is the second of two companion papers that examine the emotional wellness of children with cystic fibrosis (CF) during the early years of life, defined here as the period between birth and age 12. Both papers promote optimal mental health and well-being, with an emphasis on early identification and intervention. The first paper explores child and family resilience. Here, we discuss strategies for pediatric CF teams to provide routine, systematic mental health assessment, anticipatory guidance, brief intervention, and triage to evidence-based treatment when needed, while addressing barriers to accessing care. Many mental health conditions emerge before the age of 12, with the potential for lifelong effects on individuals, their families, and society. Living with a chronic illness such as CF can further increase the risk of mental health concerns and, in a bidirectional manner, their consequences for the quality of life, sustaining daily care, and health outcomes. There has been a significant focus in recent years on the mental health and wellness of adolescents and adults with CF, but less attention to specifics of depression and anxiety in younger children, or to other common pediatric comorbidities including trauma, developmental disorders such as attention-deficit/hyperactivity disorder or autism spectrum disorder, and oppositional behavior. Given the availability of psychometrically sound screening instruments and effective interventions, routinely addressing the mental health of children with CF and their families is feasible to integrate within multidisciplinary CF care, allowing for a personalized approach respecting individual needs, values, and goals.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  anxiety; attention-deficit hyperactivity disorder; child development disorders; cystic fibrosis; depression; posttraumatic stress disorders; social dimensions of pulmonary medicine

Mesh:

Year:  2021        PMID: 32706527     DOI: 10.1002/ppul.24977

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  1 in total

1.  Evaluating Differences in the Disease Experiences of Minority Adults With Cystic Fibrosis.

Authors:  Kia Hutchins; Eileen Barr; Cecelia Bellcross; Nadia Ali; William R Hunt
Journal:  J Patient Exp       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.